These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35317946)

  • 1. Genomic mutation analysis of circulating tumor DNA in metastatic cutaneous squamous cell carcinoma.
    Sawamura S; Myangat TM; Kajihara I; Tanaka K; Kanemaru H; Nishimura Y; Kashiwada-Nakamura K; Makino K; Aoi J; Masuguchi S; Fukushima S
    J Dermatol Sci; 2022 Apr; 106(1):61-64. PubMed ID: 35317946
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma.
    Kim EY; Ruiz ES; Hanna GJ; Thakuria M; Silk AW
    J Am Acad Dermatol; 2024 Feb; 90(2):427-429. PubMed ID: 37844691
    [No Abstract]   [Full Text] [Related]  

  • 3. The application of circulating tumor DNA in advanced cutaneous squamous cell carcinoma: Potential opportunities and challenges.
    Sun H; Shen W; Zhong HJ
    J Am Acad Dermatol; 2024 Aug; 91(2):e31-e32. PubMed ID: 38593973
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
    Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
    J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma.
    Harwood CA; Proby CM; Inman GJ; Leigh IM
    Acta Derm Venereol; 2016 Jan; 96(1):3-16. PubMed ID: 26084328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of circulating tumor cells in peripheral blood: Detection of heterogeneous BRAF mutations in a patient with advanced melanoma by single-cell analysis.
    Kiniwa Y; Nakamura K; Mikoshiba A; Akiyama Y; Morimoto A; Okuyama R
    J Dermatol Sci; 2018 May; 90(2):211-213. PubMed ID: 29426605
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
    Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets.
    Ashford BG; Clark J; Gupta R; Iyer NG; Yu B; Ranson M
    Head Neck; 2017 Jul; 39(7):1462-1469. PubMed ID: 28370784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.
    Ashida A; Sakaizawa K; Mikoshiba A; Kiniwa Y; Okuyama R
    Acta Derm Venereol; 2019 Nov; 99(12):1184-1185. PubMed ID: 31396634
    [No Abstract]   [Full Text] [Related]  

  • 12. The microRNA landscape of cutaneous squamous cell carcinoma.
    Konicke K; López-Luna A; Muñoz-Carrillo JL; Servín-González LS; Flores-de la Torre A; Olasz E; Lazarova Z
    Drug Discov Today; 2018 Apr; 23(4):864-870. PubMed ID: 29317340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous Cell Carcinoma and Multiple Familial Trichoepitheliomas: A Recurrent Association.
    Dubois A; Mestre T; Oliphant T; Husain A; Rajan N
    Acta Derm Venereol; 2018 Oct; 98(9):910-911. PubMed ID: 29972217
    [No Abstract]   [Full Text] [Related]  

  • 14. MAGEA3 Expression in Cutaneous Squamous Cell Carcinoma Is Associated with Advanced Tumor Stage and Poor Prognosis.
    Abikhair M; Roudiani N; Mitsui H; Krueger JG; Pavlick A; Lee J; Therrien JP; Meehan SA; Felsen D; Carucci JA
    J Invest Dermatol; 2017 Mar; 137(3):775-778. PubMed ID: 27826009
    [No Abstract]   [Full Text] [Related]  

  • 15. Deep ctDNA Profiling Demonstrates Genomic Features of Metastatic Disease.
    Cancer Discov; 2022 Sep; 12(9):2016. PubMed ID: 35904313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring Melanoma Using Circulating Free DNA.
    Diefenbach RJ; Lee JH; Rizos H
    Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.
    Campos MA; Macedo S; Fernandes MS; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640663
    [No Abstract]   [Full Text] [Related]  

  • 19. Liquid biopsy in head and neck squamous cell carcinoma: Prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review.
    Lauritano D; Oberti L; Gabrione F; Lucchese A; Petruzzi M; Carinci F; Lo Muzio L
    Oral Oncol; 2019 Oct; 97():7-17. PubMed ID: 31421474
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
    Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
    Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.